Characterization of CXCR4 Expression in Chondrosarcoma of Bone.

Context.-Alterations in molecular elements derived from the CXC chemokine receptor 4 (CXCR4)/stromal-derived factor 1 (SDF-1) cytokine system have been found to strongly correlate with neoplastic progression leading to metastasis in a number of tumors, including osteosarcoma. Excluding hematologic m...

Descripción completa

Detalles Bibliográficos
Publicado en:Archives of Pathology & Laboratory Medicine Vol. 135; no. 6; pp. 753 - 759
Autores principales: Bai, Shuting, Wang, Dezhi, Klein, Michael J., Siegal, Gene P.
Formato: pictorial research tables/charts Journal Article
Publicado: College of American Pathologists Jun2011
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=66926720&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 66926720
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00039985
        1FS
      jtl: Archives of Pathology & Laboratory Medicine
      issn: 00039985
      maglogo: N
    pubinfo:
      dt: Jun2011
      vid: 135
      iid: 6
      pid: 2550
      pub: College of American Pathologists
      place: Northfield, Illinois
    artinfo:
      ui:
        66926720
        66926720
        104637593
        10.5858/2009-0230-oa.1
        66926720
      ppf: 753
      ppct: 6
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Characterization of CXCR4 Expression in Chondrosarcoma of Bone.
      aug:
        au:
          Bai, Shuting
          Wang, Dezhi
          Klein, Michael J.
          Siegal, Gene P.
        affil: Department of Pathology, University of Alabama at Birmingham
      sug:
        subj:
          Bone Neoplasms Metabolism
          Chondrosarcoma Metabolism
          Tumor Markers, Biological Metabolism
          Cell Differentiation
          Human
          Adult
          Middle Age
          Aged
          Aged, 80 and Over
          Female
          Male
          Bone Neoplasms Diagnosis
          Chondrosarcoma Diagnosis
          Immunohistochemistry
          Retrospective Design
          Mann-Whitney U Test
          Funding Source
          P-Value
          Comparative Studies
          Neoplasm Staging
          Adult: 19-44 years
          Middle Aged: 45-64 years
          Aged: 65+ years
          Aged, 80 & over
          Female
          Male
      ab: Context.-Alterations in molecular elements derived from the CXC chemokine receptor 4 (CXCR4)/stromal-derived factor 1 (SDF-1) cytokine system have been found to strongly correlate with neoplastic progression leading to metastasis in a number of tumors, including osteosarcoma. Excluding hematologic malignancies, chondrosarcoma of bone is the most common primary malignant tumor of bone in adults in the United States. Like osteosarcoma, chondrosarcoma preferentially metastasizes to lung, bone, and very rarely to regional lymph nodes. However, the role of the signal pathway(s) driving neoplastic progression in chondrosarcoma has not yet been clearly elucidated. Objective.-To test whether CXCR4 was detectable in chondrosarcoma and whether CXCR4 expression levels correlated with chondrosarcoma grade. Design.-Twenty-two chondrosarcoma samples banked at our institution between 2001 and 2006 were retrieved for study. By using invasive ductal carcinoma of the breast and osteosarcoma as the positive controls, immunohistochemistry was performed on paraffin-embedded tissue sections and the intensity of the tumor cells was analyzed by morphometric techniques. Results.-All chondrosarcoma cases (22 of 22) were immunoreactive for CXCR4. However, the staining intensity of the CXCR4 between the low- and high-grade groups was significantly different. There was a higher staining intensity in high-grade chondrosarcoma cells (P < .001). Conclusion.-CXCR4 is expressed in chondrosarcomas. CXCR4 expression levels were higher in high-grade chondrosarcoma cells than in low-grade specimens. A larger number of cases will be required to confirm these results and expand the observation, but preliminary data would argue for CXCR4 immunohistochemistry as a potential marker for biologic aggressiveness in chondrosarcoma of bone.
      pubtype: Academic Journal
      doctype:
        pictorial
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N